Optimum Investment Advisors grew its position in shares of Morgan Stanley (NYSE:MS) by 30.4% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 15,226 shares of the financial services provider’s stock after buying an additional 3,552 shares during the quarter. Optimum Investment Advisors’ holdings in Morgan Stanley were worth $733,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors have also recently made changes to their positions in the company. Catamount Wealth Management lifted its holdings in shares of Morgan Stanley by 0.3% during the 2nd quarter. Catamount Wealth Management now owns 32,477 shares of the financial services provider’s stock valued at $1,447,000 after buying an additional 100 shares during the last quarter. HM Payson & Co. lifted its holdings in Morgan Stanley by 1.4% in the 2nd quarter. HM Payson & Co. now owns 7,457 shares of the financial services provider’s stock worth $332,000 after purchasing an additional 106 shares during the last quarter. Davidson & Garrard Inc. lifted its holdings in Morgan Stanley by 2.2% in the 2nd quarter. Davidson & Garrard Inc. now owns 5,525 shares of the financial services provider’s stock worth $246,000 after purchasing an additional 120 shares during the last quarter. Omnia Family Wealth LLC lifted its holdings in Morgan Stanley by 5.8% in the 2nd quarter. Omnia Family Wealth LLC now owns 2,429 shares of the financial services provider’s stock worth $108,000 after purchasing an additional 134 shares during the last quarter. Finally, Savant Capital LLC lifted its holdings in Morgan Stanley by 1.9% in the 2nd quarter. Savant Capital LLC now owns 9,863 shares of the financial services provider’s stock worth $439,000 after purchasing an additional 186 shares during the last quarter. Institutional investors and hedge funds own 85.60% of the company’s stock.
Several equities research analysts recently weighed in on the company. Oppenheimer restated a “hold” rating on shares of Morgan Stanley in a report on Tuesday, October 17th. Berenberg Bank restated a “hold” rating and issued a $40.00 target price on shares of Morgan Stanley in a report on Thursday, September 21st. Zacks Investment Research upgraded Morgan Stanley from a “hold” rating to a “buy” rating and set a $59.00 target price for the company in a report on Monday. Buckingham Research boosted their target price on Morgan Stanley from $54.00 to $57.00 and gave the stock a “buy” rating in a report on Wednesday, October 18th. Finally, Compass Point restated a “sell” rating and issued a $38.00 target price (up from $34.00) on shares of Morgan Stanley in a report on Monday, September 25th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating, eighteen have given a buy rating and two have given a strong buy rating to the stock. Morgan Stanley has an average rating of “Buy” and an average price target of $50.89.
Shares of Morgan Stanley (NYSE MS) traded down $0.54 during midday trading on Friday, reaching $52.64. The company’s stock had a trading volume of 8,190,000 shares, compared to its average volume of 9,361,194. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 2.68. The company has a market cap of $96,125.99, a P/E ratio of 14.73, a P/E/G ratio of 1.25 and a beta of 1.64. Morgan Stanley has a 52 week low of $40.06 and a 52 week high of $54.25.
Morgan Stanley (NYSE:MS) last issued its quarterly earnings results on Tuesday, October 17th. The financial services provider reported $0.93 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.81 by $0.12. The company had revenue of $9.20 billion for the quarter, compared to the consensus estimate of $9.05 billion. Morgan Stanley had a return on equity of 10.07% and a net margin of 16.76%. The company’s revenue for the quarter was up 3.2% on a year-over-year basis. During the same period in the previous year, the business posted $0.80 EPS. sell-side analysts expect that Morgan Stanley will post 3.57 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which was paid on Wednesday, November 15th. Shareholders of record on Tuesday, October 31st were given a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 1.90%. The ex-dividend date of this dividend was Monday, October 30th. Morgan Stanley’s dividend payout ratio is currently 27.70%.
In other news, President Thomas Colm Kelleher sold 40,000 shares of the business’s stock in a transaction that occurred on Monday, October 23rd. The stock was sold at an average price of $50.59, for a total transaction of $2,023,600.00. Following the sale, the president now directly owns 692,037 shares in the company, valued at $35,010,151.83. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Keishi Hotsuki sold 25,000 shares of the business’s stock in a transaction that occurred on Tuesday, November 28th. The shares were sold at an average price of $50.00, for a total value of $1,250,000.00. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 85,247 shares of company stock worth $4,284,364. 0.35% of the stock is currently owned by company insiders.
COPYRIGHT VIOLATION WARNING: “Optimum Investment Advisors Increases Stake in Morgan Stanley (MS)” was originally posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece of content on another domain, it was illegally stolen and reposted in violation of international copyright & trademark law. The original version of this piece of content can be accessed at https://www.dispatchtribunal.com/2017/12/15/optimum-investment-advisors-increases-stake-in-morgan-stanley-ms.html.
About Morgan Stanley
Morgan Stanley is a financial holding company. The Company’s segments include Institutional Securities, Wealth Management and Investment Management. The Company’s Institutional Securities business segment provides investment banking, sales and trading, and other services to corporations, governments, financial institutions and high-to-ultra high net worth clients.
Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.